HCA Holdings (HCA) Misses Q3 EPS by 72c, Miss on Revenues; FY17 EPS Outlook Below Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
HCA Holdings (HCA) PT Lowered to $82 at Piper Jaffray Following 3Q
November 1, 2017 9:04 AM EDTPiper Jaffray lowered its price target on HCA Holdings (NYSE: HCA) to $82.00 (from $86.00) while maintaining a Overweight rating following the company's 3Q earnings report. HCA reported 3Q17 results in-line with the disappointing preannouncement driven by the strong hurricane season, weaker volumes and higher expense... More
HCA Holdings (HCA) PT Lowered to $79 at Morgan Stanley
November 1, 2017 8:55 AM EDTMorgan Stanley lowered its price target on HCA Holdings (NYSE: HCA) to $79.00 (from $85.00) while maintaining a Equalweight rating.
... MoreHCA Holdings (HCA) PT Lowered to $88 at Jefferies; Reiterates Buy
November 1, 2017 8:24 AM EDTJefferies lowered its price target on HCA Holdings (NYSE: HCA) to $88.00 (from $90.00) while maintaining a Buy rating. Jefferies expects continued M&A activity that will enable management to achieve their LT EBITDA growth target of +4-6%. That said, analyst Brian Tanquilut believes HCA's... More
